Abingdon Health (LON:ABDX) Trading 1.2% Higher – Here’s Why

Abingdon Health Plc (LON:ABDX) traded up 1.2% during mid-day trading on Friday . The stock traded as high as GBX 7 and last traded at GBX 6.83. 130,836 shares were traded during mid-day trading, a decline of 9% from the average session volume of 144,301 shares. The stock had previously closed at GBX 6.75.

Abingdon Health Stock Performance

The stock has a 50 day simple moving average of GBX 6.30 and a 200 day simple moving average of GBX 6.34. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company has a market cap of £17.14 million, a price-to-earnings ratio of -7.34 and a beta of 0.13.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.